Literature DB >> 35254576

The Debatable Role of HIPEC in Ovarian Cancer.

Eduardo Paulino1,2, Andreia Cristina Melo3,4.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35254576     DOI： 10.1245/s10434-022-11431-5

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  4 in total

1.  HIPEC: HOPE or HYPE in the fight against advanced ovarian cancer?

Authors:  C Fotopoulou; J Sehouli; S Mahner; P Harter; E Van Nieuwenhuysen; A Gonzalez-Martin; I Vergote; L Chiva; A Du Bois
Journal:  Ann Oncol       Date:  2018-08-01       Impact factor: 32.976

2.  Cytoreductive Surgery With or Without HIPEC After Neoadjuvant Chemotherapy in Ovarian Cancer: A Phase 3 Clinical Trial.

Authors:  Cascales Campos Pedro Antonio; González Gil Alida; Gil Gómez Elena; González Sánchez Rocío; Martínez García Jerónimo; Alonso Romero José Luis; Nieto Díaz Aníbal; Barceló Valcárcel Francisco; Gómez Ruiz Álvaro Jesús; Ramírez Romero Pablo; Gil Martínez José
Journal:  Ann Surg Oncol       Date:  2021-11-23       Impact factor: 5.344

3.  Comparison of survival between primary debulking surgery and neoadjuvant chemotherapy for stage III/IV ovarian, tubal and peritoneal cancers in phase III randomised trial.

Authors:  Takashi Onda; Toyomi Satoh; Gakuto Ogawa; Toshiaki Saito; Takahiro Kasamatsu; Toru Nakanishi; Tomonori Mizutani; Kazuhiro Takehara; Aikou Okamoto; Kimio Ushijima; Hiroaki Kobayashi; Kei Kawana; Harushige Yokota; Masashi Takano; Hiroyuki Kanao; Yoh Watanabe; Kaichiro Yamamoto; Nobuo Yaegashi; Toshiharu Kamura; Hiroyuki Yoshikawa
Journal:  Eur J Cancer       Date:  2020-03-13       Impact factor: 9.162

4.  Randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer (SCORPION-NCT01461850).

Authors:  Anna Fagotti; Maria Gabriella Ferrandina; Giuseppe Vizzielli; Tina Pasciuto; Francesco Fanfani; Valerio Gallotta; Pasquale Alessandro Margariti; Vito Chiantera; Barbara Costantini; Salvatore Gueli Alletti; Francesco Cosentino; Giovanni Scambia
Journal:  Int J Gynecol Cancer       Date:  2020-10-07       Impact factor: 3.437
  4 in total
  1 in total

1.  Post-Publication Discussion Regarding Cytoreductive Surgery with or Without HIPEC After Neoadjuvant Chemotherapy in Ovarian Cancer.

Authors:  Pedro Antonio Cascales Campos; Alida González Gil
Journal:  Ann Surg Oncol       Date:  2022-03-07       Impact factor: 5.344
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.